5 Patients with unresectable ICC have a median survival of less than eight months.6, 7 Systemic chemotherapy with gemcitabine and cisplatin offers an overall survival advantage in patients with advanced biliary cancer8; however, given the aggressive nature of cholangiocarcinoma and overall poor ...
A patient with unresectable advanced pancreatic cancer achieving long-term survival with Gemcitabine chemotherapy[J]. Yoshiki Okamoto,Takashi Maeba,Keitarou Kakinoki,Keiichi Okano,Kunihiko Izuishi,Hisao Wakabayashi,Hisashi Usuki,Yasuyuki Suzuki.World Journal of Gastroenterology. 2008(44)Okamoto Y,Maeba T,...
(2005) Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 100: 2426-2430 The median survival time for patients with unresectable bile-duct tumors is [similar]70 days, with standard palliative therapies aimed at biliary decompression. ...
Local recurrence from rectal cancer is a complex problem that should be managed by a multidisciplinary team. Pelvic reirradiation and intraoperative radiation should be considered in the management of these patients. Long-term survival can be achieved in patients who undergo radical surgery with negativ...
Introduction: Peri-hilar cholangiocarcinoma is an aggressive bile duct cancer. Long-term survival is possible with margin-negative surgery. Historically, u... A Acher,S Weber,T Pawlik - 《Expert Review of Gastroenterology & Hepatology》 被引量: 0发表: 2021年 LIVER TRANSPLANTATION FOR UNRESECTABLE ...
Unresectable pancreatic cancer (UPC) has low survival. With improving staging techniques and systemic therapy, local control in patients without metastatic disease may have increasing importance. We investigated whether the radiation dose used in chemoradiation (CRT) as definitive treatment for UPC and th...
A patient with unresectable advanced pancreatic cancer achieving long-term survival with Gemcitabine chemotherapy[J]. Yoshiki Okamoto,Takashi Maeba,Keitarou Kakinoki,Keiichi Okano,Kunihiko Izuishi,Hisao Wakabayashi,Hisashi Usuki,Yasuyuki Suzuki.World Journal of Gastroenterology. 2008(44)Okamoto Y,Maeba T,...
A comprehensive review of the available literature demonstrates that RFA can effectively prolong the overall survival of extrahepatic cholangiocarcinoma (CCA) and ampullary cancer, especially in cases without distant metastasis. However, this topical therapy does not confer a survival benefit in patients ...
Results : The 30-day mortality was 21% (4/19 patients). Bile leakage occurred in 2 patients, leading, in both, to fatality. Excluding the 30-day mortality, the median survival of patients with carcinoma of the gallbladder and cholangiocarcinoma was 116 days (43–200) and 202 days (47–...
BILE-DUCT OBSTRUCTIONRANDOMIZED-TRIALPROGNOSTIC-FACTORSPALLIATIVE TREATMENTPOLYETHYLENE STENTSPREDICTIVE FACTORSSURVIVALGEMCITABINESTRICTURESBackground and aimBiliary self-expandable metallic stents (SEMS) play an important role in the quality of life and palliative treatment in unresectable pancreatic cancer ...